世界中医药

目的：比较健脾生血片和右旋糖酐铁片治疗妊娠期缺铁性贫血的临床疗效，为临床治疗妊娠期缺铁性贫血提供依据。方法：选取2015年1月至2017年1月青海省人民医院收治的缺铁性贫血的妊娠期孕妇180例，随机分为观察组和对照组,每组90例。观察组给予健脾生血片口服治疗；对照组给予右旋糖酐铁片治疗。2组患者均连续治疗3个月，观察临床疗效，以及红细胞计数（RBC）、血红蛋白（Hb）、血清铁蛋白（SF）含量变化，记录不良反应。结果：观察组临床总有效率为92.05%，对照组为74.16%，2组比较差异有统计学意义(P<0.05)；2组治疗后RBC、Hb、SF均显著改善（P<0.05），且观察组各时点指标均优于对照组(P<0.05)；观察组不良反应虽低于对照组，但差异无统计学意义（P>0.05）。结论：健脾生血片治疗妊娠期孕妇缺铁性贫血的疗效显著，比右旋糖酐铁片起效更快。

English Summary:

To compare the clinical efficacy of Jianpi Shengxue Tablet and iron dextran tablet in treating gestational iron deficiencyanemia and to provide a basis in treatment.Methods:A total of 180 patients with gestational iron deficiencyanemia treated in Qinghai Provincial People's Hospital from January 2015 to January 2017 were selected and randomly divided into the control group and the observation group,with 90 patients in each group.The control group was given iron dextran tablet,and the observation group was given Jianpi Shengxue Tablet.After 3 months continuous treatment,the clinical efficacy,levels of RBC,Hb and SF in both groups were observed,and their adverse reactions were recorded.Results:The clinical effect rate of the control group and the observation group were 74.16% and 92.05%,and the rate of observation group was higher (P<0.05).Compared with before the treatment,the RBC,Hb,SF levels of both groups were increased (P<0.05),and every index of observation group was increased more than the control group (P<0.05).The adverse reactions of the observation group was better than the control group,but there was no statistical difference (P>0.05).Conclusion:There was a significant curative effect of Jianpi Shengxue Tablet in treatment of gestational iron deficiencyanemia.Jianpi Shengxue Tablet is more effective than dextran iron tablets,which is worthy of clinical application.

查看全文查看/发表评论下载PDF阅读器